logo

BOLT

Bolt Biotherapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

BOLT fundamentals

Bolt Biotherapeutics (BOLT) released its earnings on Aug 14, 2025: revenue was 1.80M (YoY +41.18%), beat estimates; EPS was -4.46 (YoY -696.43%), beat estimates.
Revenue / YoY
1.80M
+41.18%
EPS / YoY
-4.46
-696.43%
Report date
Aug 14, 2025
Earnings Call
7:00 AM on Aug 14, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

BOLT has released its 2025 Q3 earnings report, with revenue of 2.17M, reflecting a YoY change of 90.10%, and net profit of -7.14M, showing a YoY change of 52.93%. The Sankey diagram below clearly presents BOLT's revenue sources and cost distribution.

Key Indicators

Bolt Biotherapeutics (BOLT) key financial stats and ratios, covering profitability, financial health, and leverage.
Bolt Biotherapeutics (BOLT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bolt Biotherapeutics (BOLT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bolt Biotherapeutics (BOLT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bolt Biotherapeutics (BOLT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bolt Biotherapeutics (BOLT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield